Recanalization of Femoropopliteal Chronic Total Occlusions Using the ENABLER-P Balloon Catheter System

Abstract

This novel system, which provides enhanced force to a standard guidewire tip for controlled intraluminal advancement, is a promising device for the treatment of peripheral CTOs.

Primary Use of the TruePath Crossing Device for Infrainguinal Chronic Total Occlusions With Intravascular Ultrasound Evaluation

“…14 The antegrade success rate was 100% (mean lesion length 22.4±61.4 cm) using the Safe-Cross 15 and 86% (mean lesion length 8.6 cm) using the Enabler CTO crossing device. 16 Thus, in comparison with other novel devices for infrainguinal occlusive disease, the TruePath achieved initial success at an acceptable rate. However, the remaining 40% of the procedures needed the extra cost of another CTO crossing maneuver (eg, guidewire) in addition to TruePath device.…”

Endovascular Treatment of Infrainguinal Chronic Total Occlusions Using the TruePath Device: Features, Handling, and 6-Month Outcomes

“…Employed as the primary crossing device, this system was successful in traversing 32 (86%) of 37 femoropopliteal lesions averaging 86.0 mm in length. 13…”

Commentary: The ENABLER-P Balloon Catheter System: A New and Exciting Tool for Recanalization of Femoropopliteal CTOs

“…The work reported by Zeller and colleagues 1 in this issue of JEVT is of the highest caliber and will certainly open new horizons in the treatment of chronic total occlusions (CTO) in the infrainguinal arteries. Endovascular revascularization for the treatment of patients with critical limb ischemia (CLI) has developed rapidly, and a great number of patients can now be offered the less invasive treatment option.…”